Boston Scientific (NYSE:BSX) announced today that CMS granted a new technology add-on payment (NTAP) for its Eluvia system. Marlborough, Mass.-based Boston Scientific’s Eluvia drug-eluting vascular stent system received the NTAP as part of the 2021 inpatient prospective payment system (IPPS). The NTAP will be made effective on Oct. 1, 2020, to provide eligible hospitals with incremental […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
CMS rate cuts for Abiomed Impella not as bad as expected
CMS will pay 11% less for the tiny Impella heart pump made by Abiomed (NSDQ:ABMD) during the upcoming federal fiscal year — but the reduction is better than the 24% cut originally proposed. For the federal fiscal year ended Sept. 30, 2021, the rate for uni-ventricular Impella percutaneous insertion will be $71,950, down from the previous […]
CryoLife buys Ascyrus Medical
CryoLife (NYSE:CRY) announced today that it will acquire Ascyrus Medical and its Ascyrus Medical Dissection Stent. The financial terms of the deal were not disclosed. AMDS is an aortic arch remodeling device used for the treatment of acute type A aortic dissections. The acquisition will strengthen CryoLife’s position in the growing aortic repair market, according to […]
Medtronic touts cryoablation therapy study results
Medtronic (NYSE:MDT) touted results demonstrating the superiority of two of its cryoablation therapy technologies. Fridley, Minn.-based Medtronic said in a news release that trials showed the superiority of the Arctic Front advance cardiac cryoballoon and the Freezor max cardiac cryoablation catheter for the first-line treatment (before drug therapy) of recurrent symptomatic paroxysmal atrial fibrillation (PAF) when […]
Adona Medical raises $20.5M
Shifamed portfolio company Adona Medical filed an SEC Form D to confirm the sale of nearly $20.5 million in equity. Campbell, Calif.-based Adona Medical is offering more than $24.8 million in equity in a new notice that had its first sale on Aug. 20, 2020. Adona Medical does not intend for the offering to last […]
7 technologies to make a ‘new Medtronic’ even more powerful
It’s been four months since Geoff Martha took over the corner office at Medtronic (NYSE:MDT), and it’s becoming clear that he has ambitious plans for the world’s largest medical device company. During the company’s Q1 earnings call on Aug. 25, Martha said management in the coming weeks plans to outline plans for a “new Medtronic” that […]
FDA approves expanded use for Medtronic’s Evolut TAVR
Medtronic (NYSE:MDT) announced last week that it received FDA approval for revised commercial labeling on its Evolut TAVR platform. Fridley, Minn.-based Medtronic said in a news release that the revised labeling modified a precaution for the treatment of bicuspid severe aortic stenosis (AS) patients who are at low risk of mortality during surgical transcatheter aortic valve […]
TAVR sales growth was flat in July, Jefferies reports
Jefferies equity research reported that sales of transcatheter aortic valve replacement (TAVR) are better than the previous quarter with flat growth. Edwards Lifesciences (NYSE:EW) reported among its second-quarter results that TAVR sales had taken a -12% hit for the three months ended June 30, 2020. When the company reported its quarterly results, it noted that it […]
CHF Solutions closes $14.4M offering
CHF Solutions (NSDQ:CHFS) announced that it closed an underwritten public offering worth gross proceeds of approximately $14.4 million. Eden Prairie, Minn.-based CHF Solutions’ offering includes the full exercise of the underwriters’ over-allotment option to purchase additional shares and warrants, bringing the total proceeds to $14.37 million after the offering was priced last week at approximately $12.5 […]
iRhythm closes $220M offering
iRhythm Technologies (NSDQ:IRTC) announced that it closed its underwritten public offering worth proceeds of approximately $220 million. San Francisco-based iRhythm offered nearly 1.3 million shares of its common stock priced at $175 per share, including the exercise in full of the underwriters’ option to purchase 163,975 additional shares under the same terms and conditions, according to […]
TransMedics to get its virtual day with FDA panel on heart transplant tech
After a six-month pandemic-related delay, TransMedics (NSDQ:TMDX) is set to have an FDA panel review the premarket approval application for its donor heart transport technology on October 7, 2020. TransMedics’ organ care system (OCS) technology is designed to keep donated hearts, lungs and livers in near-living condition until transplantation. The FDA approved the Andover, Mass.-based company’s […]